PTX Insider Trading Activity and SEC Form 4 Filings
PTX insider trading summary
No open-market insider purchases or sales of Pernix Therapeutics Holdings, Inc. (PTX) have been reported on SEC Form 4 in the past 12 months.
Latest PTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 19, 2015 | Barry J Siegel | Senior VP and General Counsel | Buy | $22K (5,000 @ $4.49) |
| Aug 19, 2015 | Sanjay S Patel | Chief Financial Officer | Buy | $23K (5,000 @ $4.60) |
| Aug 18, 2015 | Douglas Drysdale | Chief Executive Officer | Buy | $40K (8,500 @ $4.69) |
| May 6, 2015 | Douglas Drysdale | Chief Executive Officer | Buy | $102K (16,000 @ $6.40) |
| May 6, 2015 | Sanjay S Patel | Chief Financial Officer | Buy | $13K (2,000 @ $6.42) |
| Nov 3, 2014 | Tracy Simmons Clifford | Principal Accounting Officer | Sell | $22K (2,246 @ $10.00) |
| Oct 28, 2014 | Tracy Simmons Clifford | Principal Accounting Officer | Sell | $128K (12,754 @ $10.00) |
| Jun 30, 2014 | Tracy Simmons Clifford | Principal Accounting Officer | Sell | $129K (14,300 @ $9.00) |
| Jun 30, 2014 | Tracy Simmons Clifford | Principal Accounting Officer | Sell | $4K (400 @ $9.01) |
| Jun 30, 2014 | Tracy Simmons Clifford | Principal Accounting Officer | Sell | $3K (300 @ $9.01) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.